CRISPR Therapeutics AG (MEX:CRSP) Tax Rate % : -1.91% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is CRISPR Therapeutics AG Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. CRISPR Therapeutics AG's Tax Expense for the three months ended in Dec. 2024 was MXN14.6 Mil. CRISPR Therapeutics AG's Pre-Tax Income for the three months ended in Dec. 2024 was MXN-763.5 Mil. Therefore, CRISPR Therapeutics AG's Tax Rate % for the quarter that ended in Dec. 2024 was -1.91%.

CRISPR Therapeutics AG Tax Rate % Historical Data

The historical data trend for CRISPR Therapeutics AG's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRISPR Therapeutics AG Tax Rate % Chart

CRISPR Therapeutics AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Tax Rate %

Get a 7-Day Free Trial

-0.23

0.49

0.05

-1.92

-0.99

CRISPR Therapeutics AG Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Tax Rate %	Get a 7-Day Free Trial															0.26	-0.62	-1.03	-1.03	-1.91

CRISPR Therapeutics AG Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

CRISPR Therapeutics AG's Tax Rate % for the fiscal year that ended in Dec. 2024 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2024 )	/	Pre-Tax Income (A: Dec. 2024 )
	=	74.809	/	-7563.632
	=	-0.99 %

CRISPR Therapeutics AG's Tax Rate % for the quarter that ended in Dec. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2024 )	/	Pre-Tax Income (Q: Dec. 2024 )
	=	14.599	/	-763.548
	=	-1.91 %

CRISPR Therapeutics AG Tax Rate % Related Terms

Thank you for viewing the detailed overview of CRISPR Therapeutics AG's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

CRISPR Therapeutics AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CRISPR Therapeutics AG (MEX:CRSP) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

CRSP:USA 0VRQ:UK

Address

Baarerstrasse 14, Zug, CHE, CH-6300

Website

https://www.crisprtx.com

Crispr Therapeutics AG is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.